Chiral dihydrobenzooxaphosphole ligands and synthesis thereof

US10544177B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10544177-B2
Application numberUS-201916244950-A
CountryUS
Kind codeB2
Filing dateJan 10, 2019
Priority dateDec 6, 2016
Publication dateJan 28, 2020
Grant dateJan 28, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention relates to novel phosphorous ligands useful for organic transformations. Methods of making and using the ligands in organic synthesis are described. The invention also relates to processes for preparing the novel ligands.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula II wherein, Y=PR 6 R 7 , CR 8 R 9 , NR 8 R 9 , SR 8 ; R 1 , R 6 and R 7 are each independently selected from alkyl, cycloalkyl or optionally substituted aryl; R 2 and R 2′ are each independently selected from the group consisting of hydrogen, halo, perhaloalkyl, —NR 8 R 9 , —OR 8 , —SR 8 , —Si(R 8 ) 3 , —CN, —NO 2 , —OH, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, bicycloaryl, heterobicycloaryl, —C(O)alkyl, —C(S)alkyl, —S(O) 1-2 alkyl, benzyl, aryl, heteroaryl, aryloxy and heteroaryloxy, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, benzyl, aryl and heteroaryl are unsubstituted or substituted, or where adjacent R 2 and R 2′ taken together with the carbon atoms to which they are bound to form a substituted or unsubstituted cycloalkyl or heterocyclyl; R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, halo, perhaloalkyl, —NR 8 R 9 , —OR 8 , —SR 8 , —Si(R 8 ) 3 , —CN, —NO 2 , —OH, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, bicycloaryl, heterobicycloaryl, —C(O)alkyl, —C(S)alkyl, —S(O) 1-2 alkyl, benzyl, benzyl, aryl, heteroaryl, aryloxy and heteroaryloxy, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, benzyl, aryl and heteroaryl are unsubstituted or substituted, R 8 and R 9 are each independently selected from the group consisting of hydrogen, perhaloalkyl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, benzyl, aryl, and alkyl, and the enantiomers and diastereomers thereof. 2. The compound according to claim 1 wherein R 1 is C 1-6 alkyl; R 2 and R 2′ are H; R 3 , R 4 , and R 5 are H; R 6 and R 7 are C 1-6 alkyl or aryl; and the enantiomers and diastereomers thereof. 3. The compound according to claim 1 wherein Y is PR 6 R 7 R 1 is t-butyl; R 2 and R 2′ are H; R 3 , R 4 , and R 5 are H; R 6 and R 7 are t-butyl or phenyl; and the enantiomers and diastereomers thereof. 4. The compound according to claim 1 selected from the group consisting of and the enantiomers and diastereomers thereof. 5. A compound of formula III wherein R 1 is selected from alkyl, cycloalkyl or optionally substituted aryl; R 2 , R 3 , R 4 , R 5 , and R 6 are each independently selected from the group consisting of hydrogen, halo, perhaloalkyl, —NR 13 R 14 , —OR 13 , —SR 13 , —Si(R 13 ) 3 , —CN, —NO 2 , —OH, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, bicycloaryl, heterobicycloaryl, —C(O)alkyl, —C(S)alkyl, —S(O) 1-2 alkyl, benzyl, aryl, heteroaryl, aryloxy and heteroaryloxy, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, benzyl, aryl and heteroaryl are unsubstituted or substituted; R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are each independently selected from the group consisting of hydrogen, halo, perhaloalkyl, —NR 13 R 14 , —OR 13 , —SR 13 , —Si(R 13 ) 3 , —CN, —NO 2 , —OH, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, bicycloaryl, heterobicycloaryl, —C(O)alkyl, —C(S)alkyl, —S(O) 1-2 alkyl, benzyl, aryl, heteroaryl, aryloxy and heteroaryloxy, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, benzyl, aryl and heteroaryl are unsubstituted or substituted, or where adjacent R 7 , R 8 , R 9 , R 10 , R 11 and R 12 taken together with die carbon atoms to which they are bound to form a substituted or unsubstituted cycloalkyl, aryl or heteroaryl ring; R 13 and R 14 are each independently selected from the group consisting of hydrogen, perhaloalkyl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, benzyl, aryl, and alkyl and the enantiomers and diastereomers thereof. 6. The compound according to claim 5 wherein R 1 is C 1-6 alkyl, C 3-6 cycloalkyl or optionally substituted aryl; R 2 , R 3 , R 4 , and R 5 are each independently selected from H or optionally substituted aryl or heteroaryl; R 6 is H; R 7 and R 8 are C 1-6 alkyl; R 9 , R 10 , R 11 and R 12 are independently selected from H and C 1-6 alkyl; and the enantiomers and diastereomers thereof. 7. The compound according to claim 5 wherein R 1 is C 1-6 alkyl; R 2 , R 3 , R 4 , and R 5 are H; R 6 is H; R 7 and R 8 are C 1-6 alkyl; R 9 , R 10 , R 11 and R 12 are independently selected from H and C 1-6 alkyl and the enantiomers and diastereomers thereof. 8. The compound according to claim 5 wherein R 1 is t-butyl; R 2 , R 3 , R 4 , and R 3 are H; R 6 is H; R 7 and R 8 are methyl; R 9 , R 10 , R 11 and R 12 are independently selected from H and C 1-6 alkyl and the enantiomers and diastereomers thereof. 9. The compound according to claim 5 selected from the group consisting of and and the enantiomers and diastereomers thereof.

Assignees

Inventors

Classifications

  • the ring phosphorus atom being part of a phosphine oxide or thioxide · CPC title

  • Palladium compounds · CPC title

  • C07F9/6571Primary

    having phosphorus and oxygen atoms as the only ring hetero atoms · CPC title

  • the ring phosphorus atom being part of a phosphine · CPC title

  • Iridium compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10544177B2 cover?
This invention relates to novel phosphorous ligands useful for organic transformations. Methods of making and using the ligands in organic synthesis are described. The invention also relates to processes for preparing the novel ligands.
Who is the assignee on this patent?
Boehringer Ingelheim Int
What technology area does this patent fall under?
Primary CPC classification C07F9/6571. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).